1,3-Bis(4-aminophenyl)urea

CAS No. 4550-72-5

1,3-Bis(4-aminophenyl)urea( —— )

Catalog No. M17512 CAS No. 4550-72-5

1, 3-Bis(4-aminophenyl)urea can be used for screening of ALR inhibitors by detection of hydrogen peroxide production Measured in Biochemical System.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 In Stock
50MG 138 In Stock
100MG 222 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1,3-Bis(4-aminophenyl)urea
  • Note
    Research use only, not for human use.
  • Brief Description
    1, 3-Bis(4-aminophenyl)urea can be used for screening of ALR inhibitors by detection of hydrogen peroxide production Measured in Biochemical System.
  • Description
    1, 3-Bis(4-aminophenyl)urea can be used for screening of ALR inhibitors by detection of hydrogen peroxide production Measured in Biochemical System.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    P2 Receptor
  • Recptor
    GFER
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4550-72-5
  • Formula Weight
    242.28
  • Molecular Formula
    C13H14N4O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (206.37 mM)
  • SMILES
    c1cc(ccc1N)NC(=O)Nc1ccc(cc1)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS.
molnova catalog
related products
  • APY29

    APY29 is an allosteric modulator of IRE1α; inhibits IRE1α autophosphorylation (IC50 = 280 nM) and activates IRE1α RNase activity.

  • BX430

    BX430 is used for chronic pain and cardiovascular disease and it is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity.

  • BAY-1797

    BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects.